Validation of Active-Insights Device to Measure Crying Time
Pilot & Exploratory - Validation of Active-Insights Device to Measure Crying Time
1 other identifier
interventional
13
1 country
1
Brief Summary
To assess the ability of a machine learning algorithm to accurately detect fussing and crying time in infants using accelerometery data collected from a wearable device, compared to the Barr's parent-/caregiver-completed behaviour diary.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2021
CompletedStudy Start
First participant enrolled
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
December 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedDecember 21, 2021
December 1, 2021
3 months
October 15, 2021
December 14, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Device feasibility: Comparison of device-generated versus diary-reported crying and fussing time data
Part 1: Comparison of daily crying and fussing time data generated by accelerometer and machine-learning versus crying and fussing time data reported by parental Barrs diary
4 days
Device feasibility: Comparison of device-generated versus diary-reported crying and fussing time data
Part 2: Comparison of daily crying and fussing time data generated by accelerometer and machine-learning versus crying and fussing time data reported by parental Barrs diary
7 days
Secondary Outcomes (3)
Device feasibility: Comparison of device-generated versus diary-reported crying time data
7 days
Device feasibility: Comparison of device-generated versus diary-reported fussing time data
7 days
Device feasibility: Comparison of device-generated versus diary-reported sleeping time data
7 days
Study Arms (2)
Part 1: Initial data collection for device feasibility
EXPERIMENTAL3 subjects for 4 days included to collect initial data for algoritm development for device feasibility
Part 2: Device feasibility
EXPERIMENTAL10 subjects for 7 days included to evaluate device feasibility
Interventions
Accelerometer device
Eligibility Criteria
You may qualify if:
- Aged between 4-12 weeks at screening.
- Gestational age 37 weeks - 41 weeks at birth.
- Birth weight appropriate for gestational age (AGA - weight between 10th and 90th percentile) or Large for Gestational Age (LGA - weight above the 90th percentile) determined using WHO Weight-for Age percentile guides.
- Infant has excessive crying, defined as 3 or more hours per day, during 3 or more days in the preceding week.
- No birth trauma and nonsyndromic.
- Readiness and the opportunity for parents/caregivers to fill out a study diary, questionnaires and for infant to wear device.
- Parent/caregiver with ability to understand and comply with the requirements of the study, as judged by the Investigator.
- Parent/caregiver willing and able to give informed consent for their and their infant's participation in the study.
- Infant is considered healthy, following physical exam.
You may not qualify if:
- Infants with failure to thrive, intrauterine growth retardation, haematochezia (blood in the stools), diarrhoea (watery stools that takes the shape of a container \> 12x in breastfed and \>5 in partially breastfed infants daily), or fever (38.0 degrees).
- Premature infants (\<35 weeks gestation at birth).
- Infants with congenital heart disease, immunodeficiency, asplenia, cancer, cystic fibrosis, formula-fed infants, and those with liver disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BioGaia ABlead
- Atlantia Food Clinical Trialscollaborator
- ActivInsightscollaborator
Study Sites (1)
Atlantia Clinical Trials
Cork, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2021
First Posted
December 21, 2021
Study Start
October 15, 2021
Primary Completion
January 1, 2022
Study Completion
April 1, 2022
Last Updated
December 21, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share